Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

GU Cancers 2019 | Looking to the future of RCC treatment

Michael Atkins, MD, of Georgetown University, Washington, DC, discusses the current key research priorities for renal cell carcinoma (RCC) . Speaking at the 2019 Genitourinary Cancers Symposium, held in San Francisco, CA, Dr Atkins highlights the necessity of characterizing reliable biomarkers for developing effective treatments against RCC.

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.